Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances
Go back to Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances| (AMEX: VSQTF) | Delayed: 0.44 +0.02 (4.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $ | |||
| Open | $0.40 | 52 Week Low | $ | |||
| Day High | $0.45 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $ | |||
| Volume | 125,948 | |||||
| (NYSE: VST) | Delayed: 149.30 +5.08 (3.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.22 | 52 Week High | $ | |||
| Open | $143.87 | 52 Week Low | $ | |||
| Day High | $149.45 | P/E | N/A | |||
| Day Low | $143.16 | EPS | $ | |||
| Volume | 4,608,342 | |||||

